Health Care & Life Sciences » Pharmaceuticals | Shanghai Shyndec Pharmaceutical Co. Ltd.

Shanghai Shyndec Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,336
2,733
2,661
9,004
8,380
11,166
Cost of Goods Sold (COGS) incl. D&A
1,389
1,498
1,387
5,958
4,976
6,010
Gross Income
947
1,235
1,274
3,045
3,404
5,156
SG&A Expense
723
904
819
1,829
2,309
4,132
EBIT
216
303
416
1,168
1,072
996
Unusual Expense
20
3
-
17
4
60
Non Operating Income/Expense
5
5
10
13
109
428
Interest Expense
26
58
93
305
262
216
Pretax Income
216
297
353
1,021
937
1,276
Income Tax
29
50
61
182
135
224
Equity in Affiliates
-
-
-
16
17
18
Consolidated Net Income
188
248
292
854
819
1,070
Net Income
133
190
221
477
516
706
Net Income After Extraordinaries
133
190
221
477
516
706
Net Income Available to Common
133
190
221
477
516
706
EPS (Basic)
0.23
0.33
0.38
0.83
0.46
0.65
Basic Shares Outstanding
575
575
575
575
1,110
1,092
EPS (Diluted)
0.23
0.33
0.38
0.83
0.46
0.65
Diluted Shares Outstanding
575
575
575
575
1,110
1,092
EBITDA
290
407
576
1,895
1,857
1,727
Other Operating Expense
8
28
39
49
23
28
Non-Operating Interest Income
6
11
5
17
21
127
Minority Interest Expense
55
58
71
377
303
364

About Shanghai Shyndec Pharmaceutical Co.

View Profile
Address
1320 Beijing West Road
Shanghai Shanghai 200040
China
Employees -
Website http://www.shyndec.com
Updated 07/08/2019
Shanghai Shyndec Pharmaceutical Co., Ltd. principally engages in the research, development, manufacturing, and sale of pharmaceutical products. Its product range covers anti-infective drugs, cardiovascular and cerebrovascular drugs, anti-tumour drugs, anaesthetic psychotropic drugs, as well as metabolic and endocrine drugs. The company was founded in 1996 and is headquartered in Shanghai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.